Health & Biotech
Health & Biotech
Pop the champagne as EBR becomes latest ASX biotech to achieve key catalyst
Health & Biotech
PharmAust confirms safety of MPL, poised to up dosage in MND trial
Health & Biotech
Orphan drug designation has a direct impact on drug pricing for these pharma players
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Immutep surges 46pc on trial results
Health & Biotech
ASX Health Stocks: FDA approves Imugene’s Phase 1 trial; Noxopharm says it can fight skin disease
Health & Biotech
Weed Week: Cannabis helps chronic pain and insomnia, and here’s what the TGA rules say
Health & Biotech
ASX Health Stocks: Imugene’s liver cancer platform presented at prestigious conference
Health & Biotech
Incannex’s subsidiary to open multiple psychedelic clinics to capture wide open opportunity
Health & Biotech
ASX Health Stocks: Rhythym Bio skyrockets 70pc after being granted UK CA Mark
Health & Biotech
From body scans to personalised nutrition plans: how technology is transforming the way we get fit
Health & Biotech
mTOR drug shows reverse ageing may be possible. Here’s where it puts ASX-listed PharmAust
Health & Biotech
PharmAust’s interim analysis to point the way forward for MND trial
Health & Biotech
Argenica achieves Phase 1 trial success as it works to reduce brain tissue death
Health & Biotech
Nanollose files patent for breakthrough in microbial cellulose technology
Health & Biotech
Creso Pharma advances its footprint across Asia Pacific with its line of animal care products
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.